Nuclear Radiology: Page 61

Mirada signs Copenhagen's Rigshospitalet
By AuntMinnieEurope.com staff writers
Imaging software developer Mirada Medical has received an order from the Rigshospitalet in Copenhagen for its XD3 and RTx software.
March 25, 2013
GE promotes DaTscan study results at AAN meeting
By AuntMinnieEurope.com staff writers
GE Healthcare is touting the results of a randomized study of DaTscan SPECT in adult patients with a diagnosis of possible dementia with Lewy bodies.
March 20, 2013
Piramal's florbetaben PET agent to be reviewed
By AuntMinnieEurope.com staff writers
Piramal Imaging said that the U.S. Food and Drug Administration and the European Medicines Agency have accepted the company's applications for review of its florbetaben investigational PET amyloid imaging agent.
March 20, 2013
IBA results improve in fiscal 2012
By AuntMinnieEurope.com staff writers
Radiopharmaceutical provider Ion Beam Applications (IBA) benefited from increasing market adoption and expanded use of proton therapy treatment, increasing revenues for sales and services by 8.8% during its 2012 fiscal year compared with 2011.
March 18, 2013
'Unfair' regulatory stance on radiotracers poses threat to PET's future
By Becky McCall
VIENNA - Legal and regulatory issues surrounding the production and uses of radiotracers represent a significant threat to PET imaging, a senior luminary told ECR 2013 attendees at Sunday's professional challenges session on the legal matters related to multimodality techniques.
March 10, 2013
2013 03 11 14 43 21 277 2013 03 11 Von Schulthess 70
Collaboration among specialties enhances prospects of cancer patients
By Becky McCall
VIENNA - Promoting more effective collaboration among radiologists, nuclear medicine physicians, and radiation oncologists to improve imaging and radiotherapy outcomes is a core principle underpinning the lectures in a special focus session on Friday at ECR 2013.
March 7, 2013
2013 03 06 13 03 52 101 2013 03 08 Cancer Thumb
Bayer signs Intego PET distribution deal
By AuntMinnieEurope.com staff writers
Bayer HealthCare has signed a distribution agreement for its Medrad Intego PET infusion system with Italian protection technology firm Comecer.
March 4, 2013
C-11 choline PET/MRI helps restage prostate cancer patients
By Wayne Forrest
A preliminary study by German researchers suggests that carbon-11 (C-11) choline PET/MRI may provide an alternative imaging modality to PET/CT for restaging of prostate cancer by offering equal, if not better, diagnostic performance and less radiation exposure.
January 16, 2013
Lilly's Amyvid PET agent gets European clearance
By AuntMinnieEurope.com staff writers
Eli Lilly and its subsidiary Avid Radiopharmaceuticals have received approval from the European Commission for their Amyvid (florbetapir F-18) radiopharmaceutical.
January 15, 2013
Navidea reports completion of clinical trial
By AuntMinnieEurope.com staff writers
Radiopharmaceutical developer Navidea Biopharmaceuticals said that its partner AstraZeneca has completed a clinical trial of its NAV4694 radiopharmaceutical as a biomarker for visual detection and quantification of cerebral beta amyloid in diagnosing Alzheimer's disease.
January 14, 2013
GE files applications for F-18 flutemetamol
By AuntMinnieEurope.com staff writers
The U.S. Food and Drug Administration and the European Medicines Agency have accepted applications from GE Healthcare for review of its investigational F-18 flutemetamol PET amyloid imaging agent.
January 7, 2013
RnR adds imaging reports for 6 nations
By AuntMinnieEurope.com staff writers
RnR Market Research said it has added reports on the diagnostic imaging markets in Turkey, Egypt, the United Arab Emirates, Chile, Finland, and Norway that focus on investment opportunities, analysis, and forecasts through 2018.
December 27, 2012
Previous Page
Page 61 of 90
Next Page